Since CD80 binds CTLA-4 after T cell activation, we hypothesized that the observed lack of persistence and poor anti-tumor efficiency of 19z1-CD80+ T cells could result from CTLA-4 inhibition. This evidence concerns the gene CTLA4 and neoplasm.